TLPH Earnings Date: Nov 11, 2026 (Estimated) — Talphera, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is TLPH's next earnings date?
Talphera, Inc. (TLPH) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.06.
How did TLPH do in its last earnings report?
In its most recent report on Aug 13, 2026, Talphera, Inc. posted EPS of -$0.06 versus the -$0.06 estimate, a beat of 4.0%. The stock's 1-day post-earnings move was -12.1%.
How much does TLPH stock move after earnings?
TLPH beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.3% (up or down) in the day after earnings.
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimental candidate is Niyad, a lyophilized (freeze-dried) formulation of nafamostat. This anticoagulant is currently being assessed under an investigational device exemption for its application in extracorporeal circuits. The company's development pipeline also features LTX-608, a potential anti-inflammatory and antiviral agent being explored for the treatment of numerous conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis. Furthermore, Talphera is advancing Fedsyra, a pre-filled syringe containing ephedrine, and PFS-02, a pre-filled syringe containing phenylephrine. Established in 2005, the company was previously known as AcelRx Pharmaceuticals, Inc. It adopted the name Talphera, Inc. in January 2024 and maintains its corporate headquarters in San Mateo, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | -0.06 | -0.06 | +4.00% | — | ✅ Beat | -12.14% | -15.00% | -11.43% | |
| 2026-08-12 | Q2 2026 | -0.07 | -0.06 | +14.29% | $0 | ✅ Beat | -13.57% | -15.00% | -11.43% |
| 2026-05-13 | Q1 2026 | -0.08 | -0.04 | +50.00% | $0 | ✅ Beat | -0.42% | -8.58% | -3.10% |
| 2026-03-23 | Q4 2025 | -0.07 | -0.06 | +14.29% | $0 | ✅ Beat | -3.81% | -10.97% | -8.98% |
| 2025-11-12 | Q3 2025 | -0.12 | -0.11 | +8.33% | $1,000 | ✅ Beat | -18.60% | +2.33% | -7.75% |
| 2025-08-14 | Q2 2025 | -0.12 | -0.10 | +16.67% | $0 | ✅ Beat | -1.00% | +13.31% | +128.12% |
| 2025-03-31 | Q4 2024 | -0.16 | -0.07 | +56.25% | $0 | ✅ Beat | +7.07% | +1.41% | -1.01% |
| 2024-11-13 | Q3 2024 | -0.20 | -0.13 | +35.00% | $0 | ✅ Beat | -25.61% | -20.63% | -26.97% |
Showing last 8 quarters.